FOLFOX chemotherapy can safely be given to neutropenic patients with early-stage colorectal cancer for higher dose intensity and fewer visits
Crossref DOI link: https://doi.org/10.1007/s00520-015-3059-0
Published Online: 2015-12-22
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiarotto, James A.
Dranitsaris, George
Text and Data Mining valid from 2015-12-22